Report Description

India NIPAH virus diagnostics market is anticipated to grow with an impressive CAGR in the forecast period, 2023-2027. The market is expected to grow with the projected cumulative annular growth rate on the account of surging demand for the early and efficient diagnosis of the NIPAH virus infection.

NIPAH virus is a zoonotic virus strain that has the ability to transmit from animals to humans. The virus often causes infection in animals like pigs and birds like bats. The infection if transmitted to human is quite difficult to detect, and spreads violently. The infection often takes the form of pandemic and has high mortality rate. The NIPAH virus spread in India is common and the country struggles with the outbreak every now and then. Early diagnosis of the disease and infection is necessary due to the high mortality rate of the infection. South Indian region is the most affected area in the country.

Early Diagnosis Demands Drive Market Growth

The infection of NIPAH virus spreads very rapidly and is quite dangerous with its high mortality rate. Although, transmission of the NIPAH virus from bats and pigs to humans is bit slower when compared to the COVID-19 virus, the mortality rate is higher in comparison and diagnosis becomes often difficult. Lack of identification of all the strains of the NIPAH virus, creates severe risks of delayed response at the break of infection. India has already reported three NiV outbreaks in the past-- Siliguri in 2001 and Nadia in 2007 (West Bengal) and Kozhikode and Malappuram in Kerala in 2018. After the most recent outbreak in Kozhikode in Kerala, the government is more concerned over the diagnosis. Recent pandemic situation caused by COVID-19 has alerted the population as well as the government for the importance of early diagnosis of the disease caused by infectious viruses.

Research and Development of Diagnostic Kits

Consistent research is being carried out in lieu of rising cases of NIPAH virus infections. Moreover, demands for the effective diagnosis and thus advanced testing kits further requires extended research and advanced development of the testing kits, thereby driving the growth of the India NIPAH virus diagnostics market in the next five years. Government bodies are taking initiatives and following protocols thereby supporting the rapid release of testing kits for the early and effective diagnostics of NIPAH virus infection and supports the future growth of the India NIPAH virus diagnostics market in the next five years.

Molbio Diagnostics Pvt. Ltd. has announced Truenat as a latest RT-PCR platform for the early diagnosis of NIPAH virus infection. Drugs Controller General of India (DCGI) has approved the testing kit and the company to monetize the test for the early diagnosis of the NIPAH virus infection. Signs and symptoms range from asymptomatic to acute respiratory infection and fatal encephalitis. The testing kit is presumed to be able to diagnose the viral infection spread at an earlier stage and provide the ability to control the infection spread.

Climatic Changes Influence Virus Spread and Supports Market Growth

Climatic changes adversely affect the viral infection spread. Depending on the breeding conditions of the viruses, changes in the climate increases or decreases the virus’ growth. The colder climate is expected to aid to the multiplication of the virus. Moreover, recent pandemic situation has rendered the population with weaker immunity, thus effects of the virus spread, and climate changes affects the actions of human body against the virus. Weaker immunity and lack of precautious measures further substantiate the growth of the viral infection, which in turn enhances the demand and growth of the India NIPAH virus diagnostics market in the upcoming five years.

Although government puts up regulations and restrictions for the infected population as a precautious measure towards un-infected population, but lack of consideration of the widespread infection, the instances of the infection spreads.


Click here to download the sample

Market Segmentation

The India NIPAH virus diagnostics market segmentation is based on test type, sample, end user, competitional landscape, and regional distribution. Based on test type, the market is further fragmented into RT PCR, and ELISA. Based on sample, the market is segmented into throat and nasal swabs, urine, blood, and others. The market segmentation based on end user is fragmented into hospitals & clinics, diagnostics labs, and others. The market analysis also studies the regional segmentation to devise regional market segmentation, divided among North India region, South India region, East India region, and West India region.

Company Profile

Molbio Diagnostics Pvt. Ltd., Krishgen Biosystems, MyBioSource, Inc., Liferiver Bio-Tech (United States) Corp., are some of the major market players in the country that lead the market growth analysis. New market players are also actively entering the market in the recent years and further strengthening the future market growth.

Attribute

Details

Base Year

2021

Historic Data

2017 – 2020

Estimated Year

2022

Forecast Period

2023 – 2027

Quantitative Units

Revenue in USD Million, Volume in Units, and CAGR for 2017 – 2020 and 2023 – 2027

Report Coverage

Revenue forecast, volume forecast, company share, competitive landscape, growth factors, and trends

Segments Covered

  • Test Type
  • Sample
  • End User

Regional Scope

North; South; East; West;

Key Companies Profiled

Molbio Diagnostics Pvt. Ltd., Krishgen Biosystems, MyBioSource, Inc., Liferiver Bio-Tech (United States) Corp.,

Customization Scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and Purchase Options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Report Scope:

In this report, India NIPAH virus diagnostics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • India NIPAH Virus Diagnostics Market, By Test Type:
    • RT-PCR
    • ELISA
  • India NIPAH Virus Diagnostics Market, By Sample:

o   Throat & Nasal Swabs

o   Blood

o   Urine

o   Others

  • India NIPAH Virus Diagnostics Market, By End User:
    • Hospitals & Clinics
    • Diagnostics Laboratories
    • Others
  • India NIPAH Virus Diagnostics Market, By Region:
    • South
    • West
    • North
    • East

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in India NIPAH virus diagnostics market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
India NIPAH Virus Diagnostics Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on India NIPAH Virus Diagnostics Market

4.    Voice of Customer

5.    Executive Summary

6.    India NIPAH Virus Diagnostics Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Test Type (RT-PCR v/s ELISA)

6.2.2.     By Sample (Throat & Nasal Swab, Urine, Blood, Others)

6.2.3.     By End User (Hospitals & Clinics, Diagnostics Laboratories, Others)

6.2.4.     By Company (2020)

6.2.5.     By Region

6.2.5.1.         By State (Top 3 States)

6.3.  Product Market Map

7.    North India NIPAH Virus Diagnostics Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Test Type

7.2.2.     By Sample

7.2.3.     By End User

8.    South India NIPAH Virus Diagnostics Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Test Type

8.2.2.     By Sample

8.2.3.     By End User

9.    East India NIPAH Virus Diagnostics Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Test Type

9.2.2.     By Sample

9.2.3.     By End User

10.  West India NIPAH Virus Diagnostics Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Test Type

10.2.2.  By Sample

10.2.3.  By End User

11.  Market Dynamics

11.1.              Drivers

11.2.              Challenges

12.  Market Trends and Developments

13.  Policy & Regulatory Landscape

14.  India Economic Profile

15.  Competitive Landscape

15.1.              Competition Outlook

15.2.              Company Profiles

15.2.1.  Molbio Diagnostics Pvt. Ltd.

15.2.2.  Krishgen Biosystems

15.2.3.  MyBioSource, Inc.

15.2.4.  Liferiver Bio-Tech (United States) Corp.

16.  Strategic Recommendations

17.   About Us & Disclaimer

Figures and Tables

Frequently asked questions

down-arrow

down-arrow

down-arrow

down-arrow

profile

Sakshi Bajaal

Business Consultant
Press Release

India NIPAH Virus Diagnostics Market to Establish Growth with Demand for Breathable Air Until 2027

Nov, 2021

Surging demands for early diagnosis of NiV infection is driving the growth of India NIPAH virus diagnostics market, 2017-2027.